import { TimelineData } from "../timelineTypes";

export const oxbrytaTimelineData: TimelineData = {
  "2026": {
    firstHalf: [
      {
        date: "January",
        text: "Settlement discussions and negotiations have progressed for patients alleging serious injuries linked to Oxbryta, as lawsuits continue to develop against Pfizer and Global Blood Therapeutics.",
      },
    ],
    secondHalf: [],
  },

  "2025": {
    firstHalf: [
      {
        date: "February",
        text: "Global Blood Therapeutics and Pfizer filed a motion to dismiss a class action lawsuit brought by plaintiffs in the U.S. District Court for the Northern District of California.",
      },
      {
        date: "May",
        text: "An Oxbryta lawsuit filed in San Francisco has been scheduled for trial on August 16, 2027, marking a significant milestone in the litigation process.",
      },
      {
        date: "June",
        text: "A trial date of September 2027 was set in Diana Fordâ€™s lawsuit, filed on behalf of her husband, alleging severe complications linked to Oxbryta use.",
      },
    ],
    secondHalf: [
      {
        date: "August",
        text: "Retired Judge Philip S. Gutierrez was appointed to oversee mediation efforts in Oxbryta lawsuits, aiming to facilitate potential settlements between plaintiffs and defendants.",
      },
      {
        date: "September",
        text: "Settlement discussions between plaintiffs and Pfizer began with the involvement of a mediator, signaling possible resolution efforts in multiple lawsuits.",
      },
      {
        date: "October",
        text: "Former Oxbryta patients began filing claims alleging blood clots and serious complications caused by the drug. At least 18 lawsuits were pending, with more cases expected.",
      },
      {
        date: "November",
        text: "Following the EU recall of Oxbryta due to safety concerns including blood clots and deaths, patients in the United States filed lawsuits against Pfizer and Global Blood Therapeutics seeking compensation.",
      },
      {
        date: "December",
        text: "A California woman filed a wrongful death lawsuit against Pfizer and Global Blood Therapeutics after her husband allegedly died from Oxbryta complications. Some related lawsuits have already reached settlements.",
      },
    ],
  },

  "2024": {
    firstHalf: [],
    secondHalf: [
      {
        date: "September",
        text: "Pfizer recalled Oxbryta due to increased risks of vaso-occlusive crises, blood complications, and deaths associated with the medication.",
      },
      {
        date: "October",
        text: "The first Oxbryta lawsuit was filed by Trebor Hardiman, alleging serious complications including vaso-occlusive crises and body swelling linked to the drug.",
      },
    ],
  },
};
